Israel’s Endospan (see here previously) shared good early news from the trial on 22 patients of its Nexus Aortic Arch Stent Graft System. The trial is being extended to 110 patients. 120,000+ patients suffer thoracic aortic arch disease every year in the USA and Europe.
Positive early results of heart repair trial
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.